These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 28410236)
1. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type. Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236 [TBL] [Abstract][Full Text] [Related]
2. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type. Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma. Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948 [TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Wang L; Xia ZJ; Huang HQ; Lu Y; Zhang YJ Int J Hematol; 2012 Nov; 96(5):617-23. PubMed ID: 22983648 [TBL] [Abstract][Full Text] [Related]
5. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275 [TBL] [Abstract][Full Text] [Related]
6. Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type. Li YJ; Yi PY; Li JW; Liu XL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Yao Y; Fan Z; Tang T; Jiang WQ Oncotarget; 2017 Jan; 8(3):4245-4256. PubMed ID: 28002803 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma. Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009 [TBL] [Abstract][Full Text] [Related]
8. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis. Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537 [TBL] [Abstract][Full Text] [Related]
9. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma. Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971 [TBL] [Abstract][Full Text] [Related]
10. Nomograms based on SUVmax of Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type. Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411 [TBL] [Abstract][Full Text] [Related]
12. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma. Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550 [TBL] [Abstract][Full Text] [Related]
13. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type. Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028 [TBL] [Abstract][Full Text] [Related]
14. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Li P; Jiang L; Zhang X; Liu J; Wang H BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients. Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570 [TBL] [Abstract][Full Text] [Related]
17. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site. Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518 [TBL] [Abstract][Full Text] [Related]
18. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy. Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116 [TBL] [Abstract][Full Text] [Related]
19. A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type. Xu PP; Xiong J; Cheng S; Zhao X; Wang CF; Cai G; Zhong HJ; Huang HY; Chen JY; Zhao WL EBioMedicine; 2017 Nov; 25():41-49. PubMed ID: 29056540 [TBL] [Abstract][Full Text] [Related]
20. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study. Yang Y; Zhang YJ; Zhu Y; Cao JZ; Yuan ZY; Xu LM; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Liu QF; Li YX Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]